JUNS

Jupiter Neurosciences is a biopharmaceutical company developing treatments for neurological and psychiatric disorders. The company focuses on novel therapeutic approaches targeting conditions of the central nervous system including depression, anxiety, cognitive disorders, and neurodegenerative diseases. Jupiter Neurosciences conducts research and clinical development programs aimed at bringing new treatment options to patients with significant unmet medical needs in brain health. As a clinical-stage company, Jupiter faces the typical risks of drug development including clinical trial outcomes, regulatory approval processes, and the need for substantial capital to advance its programs.